Jk Cement, Icici Lombard, Cdsl Among 4 Stock Picks By Smc Global For Decent Gains

Amid nan rising volatility successful nan Indian banal markets, home brokerage patient SMC Global Securities has suggested 4 stocks- ICICI Lombard General Insurance, Central Depository Services (India), JK Cement and Medplus Health Services - to stake amid nan scarce opportunities to make money. The brokerage has picked nan erstwhile 2 based connected their beardown method charts, while nan second 2 look to beryllium robust based connected their sound fundamentals. Here's what nan brokerage has to opportunity astir these counters:

Central Depository Services (India) | Buy | Target Price: Rs 1,595-1,610 | Stop Loss: Rs 1,125

CDSL has been nether sustained trading unit for an extended period, causing it to autumn beneath its 200-day exponential moving mean (EMA) connected nan regular charts. However, a imaginable reversal awesome emerged arsenic nan banal formed a double-bottom shape astir nan Rs 1,050 level. Following this formation, nan value rebounded sharply, reclaiming its position supra nan 200-day EMA. Technically, nan banal has now surgery retired supra nan 'W' shape (double-bottom formation), signaling a bullish reversal. A follow-up buying momentum is anticipated post-breakout, suggesting further upside potential. Therefore, 1 tin accumulate a banal successful nan scope of Rs 1,300-1,320 for nan expected upside of Rs 1,595-1,610 levels pinch extremity nonaccomplishment beneath Rs 1,125 levels.

JK Cement | Buy | Target Price: Rs 6,422 | Upside: 23%

JK Cement is simply a shaper of diversified and cement-related products, including grey cement, achromatic cement (WhiteMaxX), and allied products for illustration wall putty, gypsum plaster, tile adhesives, grouts and paints. It boasts a grey cement capacity of 24.34 MTPA, achromatic cement and wall putty capacity of 3.05 MTPA, greenish powerfulness capacity of 184.14 MW, and a 32.3 MW discarded power betterment system. It is strategically positioned to use from India’s infrastructure and lodging boom, pinch a beardown beingness successful high-growth North and Central markets. Its attraction connected costs optimization, strategical acquisition, capacity description , enhanced marketplace scope and diversification into paints positions it for semipermanent growth. Thus, it is expected that nan banal whitethorn spot a value target of Rs 6,422 successful 8 to 10 months.

ICICI Lombard General Insurance Company  | Buy | Target Price: Rs 2,090-2,100 | Stop Loss: Rs 1,700

ICICI Lombard has staged a crisp V-shaped betterment from its caller lows, successfully surging backmost supra its 200-day exponential moving mean (EMA) connected nan regular charts. The rebound has unfolded wrong a rising channel, pinch nan banal forming a higher-low pattern, indicating strengthening bullish momentum. Technically, nan banal has now surgery retired supra an ascending triangle pattern, reinforcing nan bullish structure. The betterment has been supported by rising volumes, suggesting expanding buying liking and validating nan breakout. Further upside momentum is anticipated arsenic nan banal sustains supra cardinal guidance levels. Therefore, 1 tin accumulate a banal successful nan scope of Rs 1,850-1,855 for nan expected upside of Rs 2,090-2,100 levels pinch extremity nonaccomplishment beneath Rs 1,700 levels.

Medplus Health Services | Buy | Target Price: Rs 933 | Upside: 17%

Medplus Health is successful nan business of pathological laboratory testing and manufacturing, wholesale trading and statement manufacturing of pharma, fast-moving user equipment and beauty products and rendering of guidance services to group companies and holds investments successful subsidiary companies. It operates successful 13 states and continues to grow its shop web while optimizing existing operations. The guidance anticipates sustainedGMV maturation aligned pinch nan pharma market, driven by ostentation and marketplace trends, contempt a flimsy branded pharma slowdown owed to rising backstage explanation income and seasonality. It intends to support 10-11 per cent store-level EBITDA margins while managing caller shop cannibalization. With plans for 600 yearly shop additions and enhanced operational ratio via caller warehouses, guidance is optimistic astir achieving robust maturation and operational stability. Thus, it is expected that nan banal whitethorn spot a value target of Rs 933 successful 8 to 10 months